On the other hand, other reports indicate that the activation of NF-κB is also required for tumor development in many cancer models, due to the release of proinflammatory cytokines such as TNF-α and IL-6, which can trigger prosurvival signals for tumor cells supporting their growth and progression (Karin and Greten 2005). The gene discussed is NFKB1; the disease is cancer.